Related Experiment Videos

[Pulmonary functions in children with segmental Mycoplasma pneumoniae pneumonia]

Liang-Xia Wu1, Min Wu, Dan-Ping Gu

  • 1Department of Pediatrics, Sixth People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200233, China. wuliangxia6@126.com

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|March 24, 2011
PubMed

Insights

Children with segmental Mycoplasma pneumoniae pneumonia (SMPP) experience reduced pulmonary function, particularly in small airways. Lung function significantly improves during recovery, indicating reversibility, but is more severe in multiple lesion cases.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Respiratory Medicine

Context:

  • Segmental Mycoplasma pneumoniae pneumonia (SMPP) is a common respiratory infection in children.
  • Pulmonary function abnormalities are suspected but not well-characterized in SMPP.
  • Understanding these changes is crucial for effective management and prognosis.

Purpose:

  • To investigate the impact of SMPP on various pulmonary function parameters in children.
  • To compare pulmonary function during acute and recovery phases of SMPP.
  • To identify factors influencing the severity of lung function impairment.

Summary:

  • Pulmonary function tests including FVC, FEV1, FEV1/FVC, PEF, FEF25%, FEF50%, FEF75%, and FEF25%-75% were significantly reduced in children during the acute phase of SMPP.
  • Small airway function (FEF25%-75%) showed the most significant decline.
  • Pulmonary function improved markedly during the recovery phase, with impairments being more severe in children with multiple lesion areas.

Impact:

  • Demonstrates that both large and small airways are affected in pediatric SMPP.
  • Highlights the reversibility of pulmonary function impairments post-infection.
  • Suggests that the extent of lung involvement correlates with the severity of functional deficits.
Abstract

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: